During the period 2006 to 2016, the overall net exit profits from commercialisation at IRIS was in excess of NOK 100 million. This represents 5% of all R&D turnover at the Institute. Commercialisation therefore constitutes a significant financial factor for IRIS, which also has significant R&D revenues from the commercialisation companies. It also allows our researchers gain invaluable experience to transform research into real innovations.
In 2016, IRIS Forskningsinvest disposed of all of its ownership of Calysta Inc. The company has experienced exciting growth since the merger with BioProtein AS in 2014, with an increase in value of IRIS’s shareholdings in the amount of five times the capital invested during these two years. Calysta plans, along with feed company Cargill, to build a large industrial plant for the production of protein for fish feed, based on fermentation technology from Norway.
2016 was a year where oil prices remained low. Nonetheless, the technology company Sekal AS set out to double the turnover of its real-time solutions for monitoring and automation of drilling operations. The software that Sekal delivers is based on twenty years of research at IRIS. At the beginning of 2017, it looks like that the positive trend at Sekal will continue. This is largely a consequence of the results achieved by the users of the technology, who are reporting better regularity and efficiency in their drilling operations.
Additions have been made in order to facilitate the commercialisation of a part of the technology of the Hole-in-One Producer AS (HOP) company. The main idea behind HOP is to be able to drill long horizontal production wells in a much more efficient manner than how it is presently done. An important part of the HOP concept is a powerful pulling technology that leads the drill bit and the production cord forward in the well. Such a “traction unit” also has independent value, because the installation of the production pipe in horizontal wells becomes easier when one can pull the pipe into the well instead of pushing it in. The commercialisation of Traction Unit commences in 2017.
IRIS Environment and Biosentrum AS, a company owned by IRIS Forskningsinvest, plans to establish a national testing and pilot facility for fermentation. The main purpose of the centre is to incrementally scale up R&D results on the path to industrial production and applied innovation. Leading universities and research institutes participate in the cooperation for such a national centre. It is to be located at Risavika Gas Centre, just outside of Stavanger, a facility of high technological standard that now shifted is to an important role in the field of bioeconomics. State-owned Siva purchased the plant of Norwegian Shell in 2016 and rents it out to IRIS.